CIPROFLOXACIN
- Product NDC
- 36000-297
- 11-digit product format
- 360000297
- Labeler code
- 36000
- Product ID
- 36000-297_bbf4e635-5611-4ceb-9d32-620d204a1c92
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CIPROFLOXACIN
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Baxter Healthcare Corporation
- Application
- ANDA078024
- Marketing category
- ANDA
- Marketing start
- 2008-08-04
- Marketing end
- 0000-00-00
- Substance
- CIPROFLOXACIN
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Quinolone Antimicrobial [EPC], Quinolones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status.
Dataset, Scope, Product NDC table| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|
| excluded product | product | 36000-297 | | D | Discontinued by firm | | 2026-07-31 |
| excluded package | package | 36000-297 | 36000-297-24 | D | Discontinued by firm | | 2026-07-31 |
Orange Book products#
Application-product, Trade name, Ingredient table| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|
| A078024-001 | CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | CIPROFLOXACIN | 200MG/100ML | INJECTABLE / INJECTION | | | 2008-03-18 |
| A078024-002 | CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | CIPROFLOXACIN | 400MG/200ML | INJECTABLE / INJECTION | | | 2008-03-18 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 36000-297-24 | 36000029724 | 100 mL in 1 BAG (36000-297-24) | 100 ml | 2019-12-23 | 0000-00-00 | No | No | Current |